Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The classification 'No discrete molecular host target' is a designation used in pharmacological databases like ChEMBL to identify therapeutic agents that do not interact with a specific biological macromolecule, such as a protein receptor, enzyme, or transporter (ChEMBL, 2024). These drugs typically exert their effects through non-specific chemical or physical mechanisms within the body. For example, antacids like calcium carbonate and sodium bicarbonate work by chemically neutralizing gastric hydrochloric acid to increase pH (StatPearls, 2023). Osmotic agents, such as mannitol or magnesium salts, create an osmotic gradient that draws water into the intestinal lumen or renal tubules, facilitating laxation or diuresis (DrugBank, 2024; StatPearls, 2023). Other agents in this category include activated charcoal, which physically adsorbs toxins to prevent gastrointestinal absorption, and chelating agents that sequester metal ions. Because these drugs lack a specific molecular 'lock-and-key' interaction, their pharmacodynamics are governed by their concentration and physical properties within a physiological compartment rather than affinity for a specific binding site. This category is essential for distinguishing non-specific therapeutic interventions from the majority of drugs that follow traditional receptor-based models.
Drugs in this category exert therapeutic effects through physical or chemical processes, such as chemical neutralization, osmotic gradient formation, or physical adsorption, rather than binding to specific protein targets (ChEMBL, 2024; DrugBank, 2024).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No discrete molecular host target.